» Articles » PMID: 34451911

New 2,3-Benzodiazepine Derivative: Synthesis, Activity on Central Nervous System, and Toxicity Study in Mice

Overview
Publisher MDPI
Specialty Chemistry
Date 2021 Aug 28
PMID 34451911
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We report the design and synthesis of a new diazepine derivative, 4-(4-methoxyphenyl)-2,3,4,5-tetrahydro-2,3-benzodiazepin-1-one (VBZ102), and the evaluation of its anxiolytic-like profile, memory impairment effect, and toxicity in Swiss mice. VBZ102 was evaluated for central nervous system effects in an open field, light-dark box, and novel object recognition tests under oral administration for acute and sub-acute treatment. We tested the VBZ102 toxicity in mice through a determination of LD values and examination of the biochemical and histopathological parameters. The VBZ102 induced an anxiolytic effect at different doses both in the light-dark box and open field tests. Unlike other benzodiazepines (e.g., bromazepam), a sedative effect was noted only after administration of the VBZ102 at 10.0 mg/kg.

Citing Articles

Preparation of nanodiamond anchored on copper tannic acid as a heterogenous catalyst for synthesis of 1,4-benzodiazepines derivatives.

Ghalavand R, Ghafuri H, Ardeshiri H Sci Rep. 2024; 14(1):8655.

PMID: 38622185 PMC: 11018864. DOI: 10.1038/s41598-024-58563-0.


Electrophysiological Assessment of Newly Synthesized 2,3-Benzodiazepine Derivatives for Inhibiting the AMPA Receptor Channel.

Qneibi M, Jumaa H, Bdir S, Al-Maharik N Molecules. 2023; 28(16).

PMID: 37630319 PMC: 10458471. DOI: 10.3390/molecules28166067.


BPC 157, L-NAME, L-Arginine, NO-Relation, in the Suited Rat Ketamine Models Resembling "Negative-Like" Symptoms of Schizophrenia.

Zemba Cilic A, Zemba M, Cilic M, Strbe S, Ilic S, Vukojevic J Biomedicines. 2022; 10(7).

PMID: 35884767 PMC: 9313087. DOI: 10.3390/biomedicines10071462.

References
1.
Walsh R, Cummins R . The Open-Field Test: a critical review. Psychol Bull. 1976; 83(3):482-504. View

2.
Grasso S, De Sarro G, DE Sarro A, Micale N, Polimeni S, Zappala M . Synthesis and anticonvulsant activity of novel and potent 1-aryl-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3-benzodiazepin-4-ones. Bioorg Med Chem Lett. 2001; 11(4):463-6. DOI: 10.1016/s0960-894x(00)00693-4. View

3.
Katzman M . Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness. J Affect Disord. 2011; 128 Suppl 1:S11-20. DOI: 10.1016/S0165-0327(11)70004-0. View

4.
Mejo S . Anterograde amnesia linked to benzodiazepines. Nurse Pract. 1992; 17(10):44, 49-50. DOI: 10.1097/00006205-199210000-00013. View

5.
Kovacs A, Saje A, Wong A, Ramji S, Cooper J, Pearce D . Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease. Neuropharmacology. 2012; 63(5):769-75. PMC: 3408822. DOI: 10.1016/j.neuropharm.2012.05.040. View